Home (original) (raw)

Taisho Pharmaceutical Holdings

Search

Search

MENU

Dummy

Dummy dummy dummy
dummy dummy.

At a Glance

Your health is
our specialty.

Sustainability

Our commitment to
grow and improve

History

From humble beginnings
to an industry leader

Our Business

What we do to
enrich people’s lives

Our Products

Our offerings for
all aspects of your life

About Taisho Pharmaceutical Group

At a Glance At a Glance

History History

Our Business Our Business

Our Products Our Products

Corporate News

News

News

Holdings
Organization

July 1, 2024

Announcement of new structure

Holdings
Finance

January 16, 2024

Notice Regarding the Results of the Tender Offer by Otemon Co., Ltd. for the Company Shares Etc. and Change of the Parent Company and the Largest Shareholder Among the Major Shareholders

Group Company
Products

January 16, 2024

Launch of Nanozora® 30mg Autoinjector for S.C. Injection

Group Company
Products

December 1, 2023

Notification of the Approval of Home Self-injection Guidance and Management Fees and the Derestriction of the Dosing Period for NanozoraⓇ

Group Company
R&D

August 1, 2023

Notification of Approval to Manufacture and Market Nanozora® 30mg Autoinjectors for S.C. Injection in Japan

Sustainability

Sustainability Policy Sustainability Policy

Environment Environment

Social Social

Governance Governance